VREOF — Vireo Growth Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1771706 ·
Last close
$10.71
Market Cap
$544.24M
52W High
$22.50
52W Low
$8.91
ADV30
63,307
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 209,300,000 | 95,300,000 | 13,400,000 | -100,000 | 1,273,700,000 | 103,100,000 | 831,200,000 |
| Mar 2026 | 106,200,000 | 59,300,000 | 17,700,000 | -20,300,000 | 928,800,000 | 122,400,000 | 634,700,000 |
| Dec 2025 | 104,510,462 | 56,882,219 | 2,615,971 | -20,372,228 | 817,154,292 | 102,229,759 | 509,729,300 |
| Sep 2025 | 91,655,155 | 37,382,999 | 1,612,680 | -26,298,861 | 678,918,509 | 97,151,669 | 432,612,987 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$19,011,491
Investing CF
$17,859,451
Financing CF
$14,719,059
CapEx
$-40,016,673
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.00
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-319,900,000
Inventory
$76,100,000
Receivables
$35,700,000
ST Investments
$1,000,000
EBIT TTM
$-8,822,270
Pretax Income TTM
$-39,277,118
Interest Exp TTM
$30,454,848
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$511,669,280
EBITDA
$60,845,040
Free Cash Flow
$-42,946,168
Enterprise Value
$967,556,544
Total Cash
$104,100,000
Total Debt
$485,800,000
Shares Out
50,815,986
Trailing EPS
$-1.82
Book Value
$9.66
ROE
-18.9%
ROA
2.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 268,769,268 | 10,159,790 | -68,113,908 | 817,154,292 | 509,729,300 | 307,424,992 | 3,711,491 |
| Dec 2024 | 99,384,221 | 18,067,365 | -28,007,509 | 278,862,918 | 223,299,395 | 55,563,523 | -10,234,550 |
| Dec 2023 | 88,133,163 | 10,579,778 | -25,547,089 | 183,263,719 | 199,307,368 | -16,043,649 | -965,906 |
| Dec 2022 | 74,625,867 | -6,939,365 | -42,457,444 | 159,156,403 | 155,715,519 | 3,440,884 | -18,073,265 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.94
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | $542.46M | $8.21 | — |
| CBIO | CRESCENT BIOPHARMA, INC. | $539.70M | $14.53 | — |
| MNPR | Monopar Therapeutics | $561.94M | $83.72 | — |
| EOLS | Evolus, Inc. | $525.76M | $7.96 | — |
| EVO | Evotec SE | $565.07M | $1.59 | — |
News headlines (Yahoo Finance, 1h cache)
VREOF: Vireo Growth's Strong Revenue Growth Supports Price Target of $45.00
2026-08-12 09:20 · Yahoo
Vireo Growth Inc. Completes Acquisition of M3 Wellness, a Nevada Dispensary
2026-09-21 20:01 · Yahoo
Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore Settlement
2026-09-17 20:05 · Yahoo
Vireo Growth Announces Conference Attendance for September 2026
2026-09-02 20:16 · Yahoo
Vireo Growth Inc. Completes Acquisition of C21 Investments Inc.
2026-08-21 16:53 · Yahoo
Vireo Growth Inc. Announces Share Buyback Program
2026-08-13 11:00 · Yahoo
Vireo Growth Inc. Announces Second Quarter 2026 Results
2026-08-11 10:30 · Yahoo
Vireo Growth Announces Asset Based Credit Facility
2026-08-07 12:58 · Yahoo
Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assets
2026-08-07 11:00 · Yahoo
Vireo Growth to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-08-03 20:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.